Literature DB >> 1080359

Inhibitors of leukocyte chemotaxis in alcoholic liver disease.

D E Van Epps, R G Strickland, R C Williams.   

Abstract

Twenty-one of 42 patients (50 per cent) with alcoholic liver disease showed serum chemotactic inhibitory activity (CIA). CIA was not related to any single biochemical or histologic feature in the patients studied. The frequency of CIA was greatest in those with active infection. Serial studies demonstrated that CIA may be a transient phenomenon, associated with active alcoholic liver disease or appearance of infection. Nine of 15 patients showed skin test anergy; CIA was present in 8 of these 9 patients. Serum immunoglobulin A (IgA) and G (IgG) concentrations were significantly higher in patients with CIA when compared to those without CIA. Sucrose density gradient centrifugation of serums showing CIA yielded three peaks of inhibitory activity. Two had sedimentation coefficients of 10.7S and 6.8S, and the third was approximately 3S. The two higher molecular weight inhibitors were predominant in the 50 per cent ammonium sulfate precipitate. Immunoabsorption by anti-IgA but not by anti-IgG or IgM columns removed the ammonium sulfate precipitable chemotactic inhibitors. The appearance of chemotactic inhibitors in patients with alcoholic liver disease may have relevance to their apparent susceptibility to serious infections.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080359     DOI: 10.1016/0002-9343(75)90354-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  38 in total

Review 1.  Selective decontamination of the digestive tract in intensive care.

Authors:  S J Boom; G Ramsay
Journal:  Epidemiol Infect       Date:  1992-12       Impact factor: 2.451

2.  Abnormal neutrophil chemotaxis and T-lymphocyte function in staphylococcal scalded skin syndrome in an adult patient.

Authors:  P K Peterson; M Laverdiere; P G Quie; L D Sabath
Journal:  Infection       Date:  1977       Impact factor: 3.553

Review 3.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

Review 4.  Selective decontamination in intensive care practice: a review of clinical experience.

Authors:  G Ramsay; J J Reidy
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

5.  Pseudomonas putrefaciens as a cause of septicemia in humans.

Authors:  U Schmidt; R Kapila; Z Kaminski; D Louria
Journal:  J Clin Microbiol       Date:  1979-09       Impact factor: 5.948

6.  Impaired polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis.

Authors:  D H Goddard; A P Kirk; J R Kirwan; G D Johnson; E J Holborow
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

7.  Depressed delayed cutaneous hypersensitivity in alcoholic hepatitis.

Authors:  N Snyder; J Bessoff; J M Dwyer; H O Conn
Journal:  Am J Dig Dis       Date:  1978-04

8.  Defects of serum chemoattraction and polymorphonuclear leucocyte movement in patients with primary hepatocellular carcinoma.

Authors:  A G Yousif-Kadaru; R J Wyke; I A Rajkovic; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

9.  Neutrophil adherence in chronic liver disease and fulminant hepatic failure.

Authors:  M Altin; I A Rajkovic; R D Hughes; R Williams
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

10.  Monocyte function in cirrhosis.

Authors:  G Holdstock; B Leslie; S Hill; A Tanner; R Wright
Journal:  J Clin Pathol       Date:  1982-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.